| Literature DB >> 30976346 |
Nader Motallebzadeh1, Geetha Jayaprakash2, Elham Mohammadi1.
Abstract
AIM: Irrational prescribing for geriatric patients has become an important public health problem worldwide. Because India is one of the most populated countries having a great proportion of old people in the world, studies on the prevalence of inappropriate prescriptions can be very beneficial to increase the knowledge of health care providers and to reduce the occurrence of adverse drug events among this population.Entities:
Keywords: Beers Criteria; Potentially inappropriate Medication (PIM); Predictors of PIM; Prevalence of PIM
Year: 2019 PMID: 30976346 PMCID: PMC6454164 DOI: 10.3889/oamjms.2019.172
Source DB: PubMed Journal: Open Access Maced J Med Sci ISSN: 1857-9655
Prevalence of inappropriate medicine use by Beers Criteria 2015 (n = 56)
| List of medications that should be avoided based on Beers criteria 2015 independent of diagnosis | ||
|---|---|---|
| Name of drug | Strength of recommendation | Number of patients |
| Digoxin | Strong | 14 (25%) |
| Spironolactone | Strong | 11 (19.64%) |
| Indomethacin | Strong | 5 (8.92%) |
| Nitrofurantoin | Strong | 2 (3.57%) |
| nifedipine | Strong | 3 (5.35%) |
| Diazepam | Strong | 5 (8.92%) |
| Promethazine | strong | 2 (3.57%) |
| Amiodarone | strong | 2 (3.57%) |
| Amitriptyline | Strong | 3 (5.35%) |
| Metoclopramide | strong | 2 (3.57%) |
| Dicyclomine | strong | 3 (5.35%) |
| Potentially inappropriate medication use due to drug-disease or drug-syndrome interactions | ||
| Ranitidine | Strong | 3 (5.35%) |
| Fluoxetine | strong | 1 (1.78%) |
Number of patients in each group, Prevalence of PIM and Predictors of PIM using Beers Criteria 2015
| Variable | Total (n) | Patients with IMU | Patients with AMU | Prevalence (%) | Odds Ratio (CI 95%) | P value | |
|---|---|---|---|---|---|---|---|
| All | 480 | 56 | 424 | 11.66 | |||
| Age | 65-74 | 265 | 40 | 225 | 15.09 | 1 (reference) | |
| 75-84 | 152 | 12 | 140 | 7.89 | 2.074 (1.052- 4.088) | 0.035 | |
| 85 ≤ | 63 | 4 | 59 | 6.34 | 2.622 (0.902-7.622) | 0.076 | |
| Gender | Male | 218 | 29 | 189 | 13.3 | 1 (reference) | |
| female | 262 | 27 | 235 | 10.3 | 1.335 (0.764-2.333) | 0.309 | |
| No of medication | ≤ 6 | 305 | 47 | 258 | 15.4 | 1 (reference) | 0.0013 |
| 6 > | 175 | 9 | 166 | 5.14 | 3.36 (1.6-7.03) | ||
| Length of stay | ≤ 5 | 198 | 32 | 166 | 16.16 | 1 (reference) | |
| 6-10 | 207 | 20 | 187 | 9.66 | 1.802 (0.992-3.272) | 0.052 | |
| 11 ≥ | 75 | 4 | 71 | 5.33 | 3.421 (1.166-10.035) | 0.025 | |
| No of diagnosis | 1 | 54 | 14 | 40 | 25.92 | 1 (reference) | |
| 2 | 150 | 26 | 124 | 17.33 | 1.669 (0.795-3.502) | 0.175 | |
| ≥ 3 | 276 | 16 | 260 | 5.79 | 5.687 (2.579-12.541) | P < 0.0001 |
Physician’s response to various types of suggestions
| Suggestions | Accepted | Not accepted | Percentage |
|---|---|---|---|
| Further information is required for taking a clinical decision | 20 | 12 | 62.5% |
| ADR monitoring should be done | 24 | 8 | 75% |
| Specific laboratory test should be done | 19 | 13 | 59.375% |
| Use drugs with caution | 25 | 7 | 78.125% |
| The drug should be avoided | 6 | 26 | 18.75% |
| Drug dosing should be changed | 18 | 14 | 56.25% |